MONICA ELAINE TRIPODI
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family MANSFIELD, TX NPI 1356808182
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family TX CATALYST PHARMACEUTICALS, INC. All categories
General Payments — all program years on this page
$9,818.83
- Category: General Payments
- Program years: PY2021–2024
- Record count: 138
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $3,668.27 across 37 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Honoraria | $2,000.00 | 1 |
| Food and Beverage | $1,307.61 | 34 |
| Travel and Lodging | $303.97 | 1 |
| Education | $56.69 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | $2,475.74 | 3 |
| Myriad Genetic Laboratories, Inc. | $340.61 | 5 |
| Lilly USA, LLC | $186.05 | 5 |
| GlaxoSmithKline, LLC. | $143.48 | 2 |
| Janssen Biotech, Inc. | $97.47 | 1 |
| Incyte Corporation | $66.20 | 3 |
| ARRAY BIOPHARMA INC | $46.44 | 2 |
| Genentech USA, Inc. | $39.49 | 2 |
| Acerta Pharma LLC | $34.36 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $32.75 | 2 |
| Regeneron Healthcare Solutions, Inc. | $25.89 | 1 |
| Celgene Corporation | $24.97 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $23.35 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.10 | 1 |
| Merck Sharp & Dohme Corporation | $22.36 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.14 | 1 |
| Genmab U.S., Inc. | $20.91 | 1 |
| PFIZER INC. | $15.55 | 1 |
| Stemline Therapeutics Inc. | $14.26 | 1 |
| Gilead Sciences, Inc. | $14.15 | 1 |
By program year
Records — PY2024 (37)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.